Predictive value of umbilical cord blood bilirubin in neonatal hyperbilirubinemia

Abstract EN

-Introduction: Jaundice is a clinical condition that is often present in pediatric practice and constitutes one of the major issues within the neonatal period.

It occurs in both the physiological and pathological processes in newborns.1 Although most newborns with jaundice are otherwise healthy, they need to be monitored because bilirubin is potentially toxic to the central nervous system.2 The American Academy of Pediatrics (AAP) in 2004 recommended that newborns discharged within 48 h should have follow up visits after 2–3 days to detect significant jaundice.3 Aim of the work: This study was done to evaluate the predictive value of umbilical cord bilirubin in identifying infants for subsequent hyperbilirubinemia, in full-term (FT) and late pre-term (PT) newborns.

Subjects and methods: This study is a prospective clinical study which was carried out on 94 newborns taken from the delivery room (DR) and neonatal intensive care unit (NICU) of Ismailia General Hospital at Ismailia Governorate.

The study population was followed up clinically and by laboratory investigations from birth and daily during the first week of life.

Results: The study population consisted of 50 males and 44 females with the mean gestational age of 38.70 ±1.38 weeks in FT compared to 35.62 ±0.64 in late PT.

It was shown that 40.4% of PT needed treatment in the form of phototherapy compared to 29.8% of FT, and no one of both groups needed exchange transfusion.

The mean total cord bilirubin was higher among males, preterm, cesarean deliveries, and ABO and RH incompatibility positive newborns.

It was found that when cord blood in late PT newborns was P1.75 mg/dl and P1.85 mg/dl in FT newborns, there was a probability that those newborns may need phototherapy and when the levels of total cord bilirubin